PMC 9741068
1015 Patient-reported and transfusion-related outcomes in alpha- and beta-transfusion-dependent thalassemia: A multi-region real-world survey Janet Kwiatkowski 1 , Khaled Musallam 2 , Maria Domenica Cappellini 3 , Christina Chamberlain 4 , Amey Rane 4 , Keely Gilroy 4 , Susan Morris 4 , Emma Chatterton 5 , Katie Lewis 5 , Brianne Kerr 5 , Ali Taher 6 1 Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, USA, 2 Burjeel Medical City, Abu Dhabi, United Arab Emirates, 3 Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy, 4 Agios Pharmaceuticals, Cambridge, Massachusetts, USA, 5 Adelphi Real World, Bollington, UK, 6 American University of Beirut Medical Centre, Beirut, Lebanon Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1015 Aims The aim of this analysis was to characterize humanistic disease burden and transfusion-related outcomes among adults with transfusion-dependent thalassemia (TDT) globally

Health Tests Genetic methylation testing, three levels From USD 229 USD 160 What is the GSTM1 gene test
shes also become a bona fide celebrity in her own right thanks to her bold personality and proud body positivity
Indemnification To the extent permitted by law, you agree to defend, indemnify, and hold harmless BGX and its owners, officers, employees, contractors, suppliers, and agents from third-party claims, losses, liabilities, penalties, damages, and reasonable costs arising from your breach of these Terms, unlawful conduct, prohibited use, negligent handling, unauthorized resale or transfer, or violation of another persons rights